Chemotherapy for advanced NSCLC: Will meta-analysis provide the answer?

Chest

Volumn 109, Issue 5 SUPPL., 1996, Pages

  Le Chevalier, Thierry ^a  

^a INSTITUT GUSTAVE ROUSSY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; ETOPOSIDE; VINCA ALKALOID;

ADVANCED CANCER; CANCER CHEMOTHERAPY; CANCER SURVIVAL; CONFERENCE PAPER; DOSE RESPONSE; HUMAN; LIFE EXPECTANCY; LUNG NON SMALL CELL CANCER; META ANALYSIS; PRIORITY JOURNAL; RECURRENCE RISK; RISK BENEFIT ANALYSIS;

CARCINOMA, NON-SMALL-CELL LUNG; HUMANS; LUNG NEOPLASMS; META-ANALYSIS; SURVIVAL RATE;

EID: 0029866713     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Cormier Y, Bergeron Rj, La Forge J, et al. Benefits of polychemotherapy in advanced non-small cell bronchogenic carcinoma. Cancer 1982; 50:845-49
2. Rapp E, Pater JL, Willan A, et al. Chemotherapy can prolong survival in patients with advanced non-small cell cancer: report of a Canadian multicenter randomized trial. J Clin Oncol 1988; 6:633-41
3. Ganz PA, Filgin RH, Haskell CM, et al. Supportive care versus supportive care and combination chemotherapy in metastatic non-small cell lung cancer. Cancer 1989; 63:1271-78
4. Woods RL, Williams CJ, Levi J, et al. A randomized trial of cisplatin and vindesine vs supportive care only in advanced non-small cell lung cancer. Br J Cancer 1990; 61:608-11
5. Cellerino R, Tummarello D, Guidi F, et al. A randomized trial of alternating chemotherapy versus best supportive care in advanced non-small cell lung cancer. J Clin Oncol 1991; 9:1453-61
6. Quoix E, Deitemann A, Charbonneau J, et al. La chimiotherapie comportant du cisplatin est-elle utile dans la cancer bronchique non microcellulaire au stade IV?: resultats d'une etude randomisee. Bull Cancer 1991; 78:341-46
7. Kaasa S, Lund E, Thorud E, et al. Symptomatic treatment vs combination chemotherapy for patients with extensive non-small cell lung cancer. Cancer 1991; 67:2443-47
8. Buccheri GF, Ferrigno D, Curcio A, et al. Continuation of chemotherapy vs supportive care alone in patients with inoperable non-small cell lung cancer and stable disease after two or three cycles of MACC. Cancer 1989; 63:428-32
9. Souquet PJ, Chauvin F, Boissel JP, et al. Polychemotherapy in advanced non-small cell lung cancer: a meta-analysis. Lancet 1993; 342:19-21
10. Grilli R, Oxman AD, Julian JA. Chemotherapy for advanced non-small cell lung cancer: how much benefit is enough? J Clin Oncol 1993; 11:1866-72
11. Marino P, Pampallona S, Preatoni A, et al. Chemotherapy vs supportive care in advanced non-small cell lung cancer: results of a meta-analysis of the literature. Chest 1994; 106:861-65
12. Non-small Cell Cancer Collaborative Group. Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trials. BMJ 1995; 311:899-909